Caribou Biosciences, Inc. (CRBU) at a glance

Caribou Biosciences, Inc. (CRBU) is a micro-cap Healthcare company. It trades at $1.66, with a 0% profit margin and revenue growth of 1.9%. It does not pay a dividend. Vestovix scores it 38/100 overall. Its strongest dimension is Value (53/100) and its weakest is Safety (12/100). It carries above-market volatility, so expect larger swings.

Price

$1.66

Market cap

$158.2M

P/E ratio

n/a

Dividend yield

None

Beta

2.33

52-week range

$1.38 to $3.54